Replies to post #21001 on Endonovo Therapeutics Inc (ENDV)

[Joecanada13]

Great post, thanks for sharing biotech!

[Stiggie]

Many thanks for taking your time to write this down. Much appreciated.

[king koopa]

Well done!!! We need the PR stickied with some good attention grabbing capital letters, then a link to the results/data, and the meat of the post being your write up here. A good sticky post to this effect would be great to let visitors know what is really going on here

[Bigtoker]

Great read and thank you I feel the same and am not parting with a single share till we get uplisted or boughtout . Looking really bright in ENDV land . Have a great rest of the weekend and GLTA happy Monday coming !!!

[dragon_silk]

It makes sense to me now as to why they released this news on a Friday. They may have figured it’s something the market needs to digest over the weekend. Wow, thank you so much , Biotech, for breaking it down for the rest of us!

[Retroant33]

Hey guys and girls. First post, but been here since April. Have about 170k @ just under 0.04 and haven't even thought about selling a single share. Do we have any idea the number of mice we had in each group? We do similar studies in mice for inflammatory derived disease modeling and having a large enough cohort is critically important to being able to make and support the statements from the latest pr -- especially in a peer reviewed journal setting. Anyone have a link for this info? I wasn't able to find anything...

[sello]

Well done! I appreciate you taking the time to put that together.

From what I am hearing it's the fractional shortening and ejection fraction that are the really big deal here. From my understanding the current drugs most commonly prescribed for remodeling are the beta blockers and ACE inhibitors and while they do much to decrease dilation, inhibit proinflammatory cytokines, and improve other functions, they do not do anything to increase contractility and actually often reduce it.

One of the Doctors said it looked to be a more inclusive therapy, addressing a broader array of symptoms. He also pointed out that because the results clearly pointed to dose dependency, there is a good possibility that results could be improved upon with more frequent doses and also possibly speed up the process.

Great future in ENDV. Can't wait until the other 3 trial results come. Simply unbelievable to have a non invasive device achieve these levels of efficacy. So glad I stuck it out here.

[srinsocal]

Thanks for the translation BT

Friday's PR was the "Sizzle" and many jumped in and out making a few dollars.

We now can see that there is a Big Juicy Steak on the
Grill to back up all that Sizzle.

[itsthebox1]

Killer post, thx!

[vanderhoff]

It is a major breakthrough that a non-invasive device can improve healing of the heart like this with an electromagnetic pulse. My opinion is that the only reason stock isn't trading higher is because people do not yet understand the significance of these results yet. The next step is likely going to be review and commenting by a cardiac expert who further articulates the significance of these findings. I believe there are also more results that will come out related to this study. I suspect an experienced healthcare investor is likely just around the corner. I am buying more shares at this low prices. We could see a 4-5X increase in valuation rom here as soon as an investor is announced or upon further scientific review of these findings that further demonstrates the significance.

[Craig305]

Too bad things have not progressed further with the heart here at ENDV.

A few heart and BP pharmaceuticals have recently been recalled due to cancer causing ingredient.